Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736566 · ClinicalTrials.gov registry record · NA
A Pilot Project Exploring the Impact of Whole Genome Sequencing in Healthcare
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 213
- Enrollment target
NCT01736566 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 213 participants.
The verdict
NCT01736566, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 213 participants
- Enrollment target
Study Summary
The MedSeq™ Project seeks to explore the impact of incorporating information from a patient's whole genome sequence into the practice of clinical medicine. In the extension phase of MedSeq we are attempting increase our participant diversity by increasing targeted enrollment of African/African American patient participants.
Interventions
- OTHER Family History + Whole Genome Sequencing
- OTHER Family History Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2011-12 |
| Est. Completion | 2021-01-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01736566
The ClinicalTrials.gov registry entry for NCT01736566 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Family History + Whole Genome Sequencing is the first listed.
NCT01736566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01736566 about?
NCT01736566 is a clinical study titled "A Pilot Project Exploring the Impact of Whole Genome Sequencing in Healthcare". The MedSeq™ Project seeks to explore the impact of incorporating information from a patient's whole genome sequence into the practice of clinical medicine. In the extension phase of MedSeq we are attempting increase our participant diversity by increasing targeted enrollment of African/African Ameri...
What is the current status of trial NCT01736566?
This trial is currently completed. It is a NA study. The enrollment target is 213 participants. The study started on 2011-12. Estimated completion is 2021-01-02.
What interventions are being tested in trial NCT01736566?
The interventions under investigation include: Family History + Whole Genome Sequencing (OTHER), Family History Only (OTHER).
Who is sponsoring clinical trial NCT01736566?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.